• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组编辑工具在人类疾病模型开发和治疗应用中的进展与展望。

Progress in and Prospects of Genome Editing Tools for Human Disease Model Development and Therapeutic Applications.

机构信息

Department of Physiology, Korea University College of Medicine, Seoul 02841, Republic of Korea.

Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02841, Republic of Korea.

出版信息

Genes (Basel). 2023 Feb 14;14(2):483. doi: 10.3390/genes14020483.

DOI:10.3390/genes14020483
PMID:36833410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9957140/
Abstract

Programmable nucleases, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeats (CRISPR)/Cas, are widely accepted because of their diversity and enormous potential for targeted genomic modifications in eukaryotes and other animals. Moreover, rapid advances in genome editing tools have accelerated the ability to produce various genetically modified animal models for studying human diseases. Given the advances in gene editing tools, these animal models are gradually evolving toward mimicking human diseases through the introduction of human pathogenic mutations in their genome rather than the conventional gene knockout. In the present review, we summarize the current progress in and discuss the prospects for developing mouse models of human diseases and their therapeutic applications based on advances in the study of programmable nucleases.

摘要

可编程核酸酶,如锌指核酸酶(ZFNs)、转录激活因子样效应核酸酶(TALENs)和规律成簇间隔短回文重复序列(CRISPR)/Cas,因其多样性和在真核生物和其他动物中靶向基因组修饰的巨大潜力而被广泛接受。此外,基因组编辑工具的快速发展加速了产生各种用于研究人类疾病的基因修饰动物模型的能力。鉴于基因编辑工具的进步,这些动物模型通过在其基因组中引入人类致病突变,而不是传统的基因敲除,逐渐向模拟人类疾病的方向发展。在本综述中,我们总结了基于可编程核酸酶研究进展的人类疾病小鼠模型的开发及其治疗应用的现状和前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffe/9957140/149d47cdc924/genes-14-00483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffe/9957140/149d47cdc924/genes-14-00483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ffe/9957140/149d47cdc924/genes-14-00483-g001.jpg

相似文献

1
Progress in and Prospects of Genome Editing Tools for Human Disease Model Development and Therapeutic Applications.基因组编辑工具在人类疾病模型开发和治疗应用中的进展与展望。
Genes (Basel). 2023 Feb 14;14(2):483. doi: 10.3390/genes14020483.
2
Applications of Alternative Nucleases in the Age of CRISPR/Cas9.替代核酸酶在 CRISPR/Cas9 时代的应用。
Int J Mol Sci. 2017 Nov 29;18(12):2565. doi: 10.3390/ijms18122565.
3
Basics of genome editing technology and its application in livestock species.基因组编辑技术基础及其在牲畜物种中的应用。
Reprod Domest Anim. 2017 Aug;52 Suppl 3:4-13. doi: 10.1111/rda.13012.
4
Construction and Evaluation of Zinc Finger Nucleases.锌指核酸酶的构建与评估。
Methods Mol Biol. 2023;2637:1-25. doi: 10.1007/978-1-0716-3016-7_1.
5
Concerns regarding 'off-target' activity of genome editing endonucleases.对基因组编辑内切酶“脱靶”活性的关注。
Plant Physiol Biochem. 2018 Oct;131:22-30. doi: 10.1016/j.plaphy.2018.03.027. Epub 2018 Mar 28.
6
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.基因组编辑技术在人类疾病靶向治疗中的应用:机制、进展与展望。
Signal Transduct Target Ther. 2020 Jan 3;5(1):1. doi: 10.1038/s41392-019-0089-y.
7
A beginner's guide to gene editing.基因编辑初学者指南。
Exp Physiol. 2018 Apr 1;103(4):439-448. doi: 10.1113/EP086047. Epub 2018 Jan 25.
8
Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9.测量和减少包括CRISPR-Cas9在内的可编程核酸酶的脱靶活性。
Mol Cells. 2015 Jun;38(6):475-81. doi: 10.14348/molcells.2015.0103. Epub 2015 May 19.
9
In Vivo Delivery Systems for Therapeutic Genome Editing.用于治疗性基因组编辑的体内递送系统
Int J Mol Sci. 2016 Apr 27;17(5):626. doi: 10.3390/ijms17050626.
10
Genome Editing in Stem Cells for Disease Therapeutics.用于疾病治疗的干细胞基因组编辑
Mol Biotechnol. 2018 Apr;60(4):329-338. doi: 10.1007/s12033-018-0072-9.

引用本文的文献

1
Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases.基因编辑与纳米技术在基于干细胞的人类疾病治疗中的应用。
Stem Cell Rev Rep. 2025 Feb 27. doi: 10.1007/s12015-025-10857-0.
2
Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes.在恒河猴中进行人NTCP的肝脏特异性转基因表达可使原代肝细胞对乙肝病毒易感。
Proc Natl Acad Sci U S A. 2025 Feb 18;122(7):e2413771122. doi: 10.1073/pnas.2413771122. Epub 2025 Feb 12.

本文引用的文献

1
TadA reprogramming to generate potent miniature base editors with high precision.TadA 重编程以产生具有高精度的强效微型碱基编辑器。
Nat Commun. 2023 Jan 26;14(1):413. doi: 10.1038/s41467-023-36004-2.
2
The compact Casπ (Cas12l) 'bracelet' provides a unique structural platform for DNA manipulation.紧凑型 Casπ(Cas12l)“手链”为 DNA 操作提供了独特的结构平台。
Cell Res. 2023 Mar;33(3):229-244. doi: 10.1038/s41422-022-00771-2. Epub 2023 Jan 17.
3
CRISPR-mediated generation and characterization of a Gaa homozygous c.1935C>A (p.D645E) Pompe disease knock-in mouse model recapitulating human infantile onset-Pompe disease.
CRISPR 介导的 Gaa 纯合 c.1935C>A(p.D645E)庞贝病敲入小鼠模型的建立与特征分析,该模型模拟了人类婴儿期发病-庞贝病。
Sci Rep. 2022 Dec 14;12(1):21576. doi: 10.1038/s41598-022-25914-8.
4
Prime editing for precise and highly versatile genome manipulation.碱基编辑技术实现精准且多功能的基因组编辑。
Nat Rev Genet. 2023 Mar;24(3):161-177. doi: 10.1038/s41576-022-00541-1. Epub 2022 Nov 7.
5
Enhancement of Gene Editing and Base Editing with Therapeutic Ribonucleoproteins through In Vivo Delivery Based on Absorptive Silica Nanoconstruct.基于吸收性硅纳米结构的体内递送实现治疗性核糖核蛋白增强基因编辑和碱基编辑
Adv Healthc Mater. 2023 Feb;12(4):e2201825. doi: 10.1002/adhm.202201825. Epub 2022 Nov 10.
6
Guide RNA engineering enables efficient CRISPR editing with a miniature Syntrophomonas palmitatica Cas12f1 nuclease.引导RNA工程可利用小型棕榈油互营单胞菌Cas12f1核酸酶实现高效的CRISPR编辑。
Cell Rep. 2022 Sep 27;40(13):111418. doi: 10.1016/j.celrep.2022.111418.
7
Genome editing-mediated knock-in of therapeutic genes ameliorates the disease phenotype in a model of hemophilia.在血友病模型中,基因组编辑介导的治疗性基因敲入改善了疾病表型。
Mol Ther Nucleic Acids. 2022 Aug 4;29:551-562. doi: 10.1016/j.omtn.2022.08.002. eCollection 2022 Sep 13.
8
A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing.杜氏肌营养不良的人源化敲入小鼠模型及其通过CRISPR-Cas9治疗性基因编辑的校正。
Mol Ther Nucleic Acids. 2022 Aug 1;29:525-537. doi: 10.1016/j.omtn.2022.07.024. eCollection 2022 Sep 13.
9
Efficient genome editing in wild strains of mice using the i-GONAD method.利用 i-GONAD 方法对野生型小鼠进行高效的基因组编辑。
Sci Rep. 2022 Aug 15;12(1):13821. doi: 10.1038/s41598-022-17776-x.
10
CRISPR base editing of cis-regulatory elements enables the perturbation of neurodegeneration-linked genes.CRISPR 碱基编辑技术可用于调控元件的修饰,从而对与神经退行性疾病相关的基因进行干扰。
Mol Ther. 2022 Dec 7;30(12):3619-3631. doi: 10.1016/j.ymthe.2022.08.008. Epub 2022 Aug 13.